Pearl Pathway’s recent expansion to parent Pearl IRB as well as two new divisions, Pearl ReGXP and Pearl IDEAS, was featured on Center Watch News Online on October 17th. To read the full article from Center Watch, go here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.